|
LOBBYING REPORT |
Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page
2. Address
Address1 | 1100 15th Street, NW, Suite 400 |
Address2 | |
City | WASHINGTON |
State | DC |
Zip Code | 20005 |
Country | USA |
3. Principal place of business (if different than line 2)
City | |
State | |
Zip Code | |
Country | |
|
5. Senate ID# 3071-12
|
||||||||
|
6. House ID# 316200000
|
TYPE OF REPORT | 8. Year | 2008 |
Q1 (1/1 - 3/31) | Q2 (4/1 - 6/30) | Q3 (7/1 - 9/30) | Q4 (10/1 - 12/31) |
9. Check if this filing amends a previously filed version of this report
10. Check if this is a Termination Report | Termination Date | |
11. No Lobbying Issue Activity |
INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13 | |||||||||
---|---|---|---|---|---|---|---|---|---|
12. Lobbying | 13. Organizations | ||||||||
INCOME relating to lobbying activities for this reporting period was: | EXPENSE relating to lobbying activities for this reporting period were: | ||||||||
|
|
||||||||
|
|
||||||||
Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). | 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options. | ||||||||
Method A.
Reporting amounts using LDA definitions only
Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code Method C. Reporting amounts under section 162(e) of the Internal Revenue Code |
Signature | Digitally Signed By: Allison C. Wiley, Political Action Coordinator |
Date | 01/16/2009 |
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code PHA
16. Specific lobbying issues
H.R. 6353 - Ryan Haight Online Pharmacy Consumer Protection Act of 2008 (Public Law 110-425)
H.R. 5839 - Safeguarding Americas Pharmaceuticals Act of 2008
H. Res. 1437 - Designates October as American Pharmacists Month
H.R. 971 - Community Pharmacy Fairness Act
H.R. 6357 - Protecting Records, Optimizing Treatment, and Easing Communication through Healthcare Technology (PRO(TECH)T) Act of 2008
(Docket Number: FDA-2008-N-0162) Agency Information Collection Activities; Submission for Office of management and Budget Review; Comment Request; Prescription Drug Product Labeling: Medication Guide Requirements
(Docket Number: CMS0009P) HHS Proposed Rule on Health Insurance Reform; Modifications to the Health Insurance Portability and Accountability Act (HIPAA) Electronic Transaction Standards
(Docket Number: CMS-0013-P) HHS Proposed Rule HIPAA Administrative Simplification: Modification to Medical Data Code Set Standards To Adopt ICD-10-CM and ICD-10-PCS
(Docket Number: DEA-2008-0009) DEA Proposed Rule for Electronic Prescriptions for Controlled Substances
(Docket Number: FDA-2008-N-0466) FDA Over the Counter Cough and Cold Medications for Pediatric Use; Notice of Public Hearing
(Docket Number: FDA-2008-N-0038) FDA Joint Meeting of the Antiviral Drugs Advisory Committee and the Nonprescription Drugs Advisory Committee; Notice of Meeting
(Docket Number: FDA-2008-N-0038) FDA Joint Meeting of the Anesthetic and Life Support Drug Advisory Committee and the Drug Safety and Risk Management Advisory Committee; Notice of Meeting
(Docket Number: FDA2008D0417) Draft Guidance for the Public and the Food and Drug Administration Staff on Convening Advisory Committee Meetings
(Docket No. FDA2003N0313 (formerly Docket No. 2003N0342)) FDA Toll-Free Number for Reporting
Adverse Events on Labeling for Human Drug Products
(Docket Number: FDA-2008-P-0380) Citizen Petition: Requesting FDA Action on a "One Document Solution" for all Pharmacy-Based Communications
(Docket Number: FDA2008N0612) Sentinel Initiative: Structure, Function, and Scope; Public Workshop; Request
for Comments
(Public Law 110-85) Food and Drug Administration Amendments Act of 2007 Section on Adverse Event Reporting Requirement
Concept (No Bill Language): Role of Pharmacist-Provided Patient Care Services in Health Care Reform
Concept (No Bill Language): U.S. Office of Inspector General (OIG) Exclusions List of Certain Health Care Providers who Have Engaged in Fraudulent or Abusive Behavior from Participating in Federally Funded Health Care Programs
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Office of Management & Budget (OMB), Health & Human Services - Dept of (HHS), Food & Drug Administration (FDA), Drug Enforcement Administration (DEA), Centers For Medicare and Medicaid Services (CMS)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Kristina |
Lunner |
|
|
|
Hrant |
Jamgochian |
|
|
|
Marcie |
Bough |
|
Former Legislative Assistant in Senate |
|
Harry |
Hagel |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code HCR
16. Specific lobbying issues
H.R. 6680 - The Community and AIDS and Hepatitis Act
H.R. 2994/ S. 3387 - National Pain Care Policy Act of 2007
S. 2176 Methamphetaime Production Act (Public Law 110-415)
Under Line 17: We would like to include the Agency for Healthcare Research and Quality (AHRQ)
(Docket Number: HHS-OS-2008-0011) HHS Proposed Rule on Ensuring that Department of Health and Human Services Funds Do Not Support Coercive or Discriminatory Policies or Practices In Violation of Federal Law
(Docket Number: AHRQ_FRDOC_0001-0054) Implementing the Patient Safety and Quality Improvement Act of 2005 Including How to Become a Patient Safety Organization: Interim Guidance Availability
(Docket Number: RIN 0919AA01) Patient Safety and Quality Improvement (Final Rule)
(Docket Number: RIN 1545BE30) Employer Comparable Contributions to Health Savings Accounts Under Section 4980G
(Public Law 109-41) Patient Safety & Quality Improvement Act of 2005
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Health & Human Services - Dept of (HHS)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Kristina |
Lunner |
|
|
|
Hrant |
Jamgochian |
|
|
|
Marcie |
Bough |
|
Former Legislative Assistant in Senate |
|
Harry |
Hagel |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code MMM
16. Specific lobbying issues
H.R. 6331/ S. 3101 - Medicare Improvements for Patients and Providers Act of 2008 (P.L. 110-275) Sections on Medicaid AMP, Medicare Part D prompt payment, DME Competitive Bidding and Accredition, Prescription Drug Pricing, Long-Term Care pharmacies, and e-prescribing
H.R. 4296/ S. 2408 - Medicare Electronic Medication and Safety Protection (E-MEDS) Act of 2007
H.R. 3700/ S. 1951 - Fair Medicaid Drug Payment Act of 2007
H.R. 3140 - Saving Our Community Pharmacies Act of 2007
S. 1827 - Pharmacist Access and Recognition in Medicare (PhARM) of 2007
H.R. 3025 - Medicare Prescription Drug Savings for Our Seniors Act of 2007
(Docket Number: CMS 4138- IFC) Medicare Program; Revisions to the Medicare Advantage and Prescription Drug Benefit Programs Sections on Prompt Payment of Clean Claims, Prescription Drug Pricing, Long-Term Care Pharmacies, Special Needs Plans, and Medication Therapy Management
(Docket Number: CMS-1404-FC) Medicare Program: Changes to the Hospital Outpatient Prospective Payment System and CY 2009 Payment Rates. Final Rule with Comment Period
(Docket Number: CMS-4121-F) CMS Final Rule on Prohibiting Midyear Changes to Medicare Advantage Plans
(Docket Number: CMS-1403-P) CMS Amendment on Medicare Program; Revisions to Amendment of the E-Prescribing Exemption for Computer-Generated Facsimiles
(Docket Number: CMS-7011-N) CMS Notice on Medicare Program: Request for Cosponsors for E-prescribing Educational Conference
(Docket Number: CMS-2238-F) Medicaid Program; Multiple Source Drug Definition
(Public Law 110-28 and Public Law 110-90) Medicaid's Tamper-Resistance Prescription Pad Requirement
(Public Law 109-171) Deficit Reduction Act of 2005 Section on Average Manufacturers Price (AMP)
(Public Law 108-173) Medicare Modernization Act (MMA) Section on Medicare Advantage and Medicare Part D Fraud, Waste, and Abuse Training
Concept (No Bill Language): Medicare Part B "Provider Status" for Pharmacists
Concept (No Bill Language): Changes to Medicare Part D Medication Therapy Management Benefit
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Health & Human Services - Dept of (HHS), Centers For Medicare and Medicaid Services (CMS)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Kristina |
Lunner |
|
|
|
Hrant |
Jamgochian |
|
|
|
Marcie |
Bough |
|
Former Legislative Assistant in Senate |
|
Harry |
Hagel |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code VET
16. Specific lobbying issues
H.R. 6122 - Veterans Pain Care Act of 2008
S. 2162 - Veterans' Mental Health and Other Care Improvements Act of 2008 (Public Law 110-387) Section on Pain Care Act
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Kristina |
Lunner |
|
|
|
Hrant |
Jamgochian |
|
|
|
Marcie |
Bough |
|
Former Legislative Assistant in Senate |
|
Harry |
Hagel |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code ENV
16. Specific lobbying issues
(Docket Number: EPA-HQ-RCRA-2007-0932) Amendment to the Universal Waste Rule: Addition of Pharmaceuticals
(Docket Number: EPAHQOW2008 0517) Agency Information Collection Activities: Proposed Collection; Comment Request; Study of Unused Pharmaceuticals from Medical and Veterinary Facilities
17. House(s) of Congress and Federal agencies Check if None
Environmental Protection Agency (EPA)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Kristina |
Lunner |
|
|
|
Hrant |
Jamgochian |
|
|
|
Marcie |
Bough |
|
Former Legislative Assistant in Senate |
|
Harry |
Hagel |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code BUD
16. Specific lobbying issues
DRAFT Economic Stimulus Bill Section on Health Information Technology
S. 3001 - National Defense Authorization Act of Fiscal Year 2009 (Public Law 110-417) Section on TRICARE
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Kristina |
Lunner |
|
|
|
Hrant |
Jamgochian |
|
|
|
Marcie |
Bough |
|
Former Legislative Assistant in Senate |
|
Harry |
Hagel |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
Information Update Page - Complete ONLY where registration information has changed.
20. Client new address
Address | |
||||||
City | |
State | |
Zip Code | |
Country | |
21. Client new principal place of business (if different than line 20)
City | |
State | |
Zip Code | |
Country | |
22. New General description of client’s business or activities
LOBBYIST UPDATE
23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client
|
|
||||||||
1 |
|
5 |
|
||||||
2 |
|
6 |
|
||||||
3 |
|
7 |
|
||||||
4 |
|
8 |
|
ISSUE UPDATE
24. General lobbying issue that no longer pertains
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
AFFILIATED ORGANIZATIONS
25. Add the following affiliated organization(s)
Internet Address:
Name | Address |
Principal Place of Business (city and state or country) |
||||||||||||
| ||||||||||||||
|
26. Name of each previously reported organization that is no longer affiliated with the registrant or client
1 | 3 | 5 |
2 | 4 | 6 |
FOREIGN ENTITIES
27. Add the following foreign entities:
Name | Address |
Principal place of business (city and state or country) |
Amount of contribution for lobbying activities | Ownership percentage in client | ||||||||||
| ||||||||||||||
|
% |
28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization
1 | 5 | 9 |
2 | 6 | 10 |
3 | 7 | 11 |
4 | 8 | 12 |